| 注册
首页|期刊导航|中国社区医师|创新性复方调血脂药物药理毒理研究

创新性复方调血脂药物药理毒理研究

蒲平 刘太圣

中国社区医师Issue(34):15-16,2.
中国社区医师Issue(34):15-16,2.DOI:10.3969/j.issn.1007-614x.2014.34.7

创新性复方调血脂药物药理毒理研究

The research of pharmacology and toxicology of innovative compound lipid regulating agents

蒲平 1刘太圣2

作者信息

  • 1. 629000四川省遂宁市第一人民医院药剂科
  • 2. 621000四川省绵阳市第三人民医院药剂科
  • 折叠

摘要

Abstract

In the non clinical research,methods of different types of compound preparation development is different.In this paper, we first analyze the characteristics of single drug in the prescription,according to compound lipid-lowering drug development accurate legislation,accurately analyze the target indication and human subjects,carry out related research on innovative compound lipid-lowering drug pharmacology and toxicology.

关键词

创新性复方调血脂药物/临床前评价/药理毒理

Key words

Innovative compound lipid regulating agents/Pre clinical evaluation/Pharmacology and Toxicology

引用本文复制引用

蒲平,刘太圣..创新性复方调血脂药物药理毒理研究[J].中国社区医师,2014,(34):15-16,2.

中国社区医师

1007-614X

访问量4
|
下载量0
段落导航相关论文